Trademarkia Logo

Canada

C$
LARIMAR THERAPEUTICS
REGISTERED

on 8 Jun 2022

Last Applicant/ Owned by

LARIMAR THERAPEUTICS INC.

Three Bala Plaza East, Suite 506Bala Cynwyd PA 19004

US

Serial Number

2053617 filed on 7th Aug 2020

Registration Number

TMA1131225 registered on 8th Jun 2022

Registration expiry Date

7th Aug 2030

LARIMAR THERAPEUTICS

Trademark usage description

pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases Read More

Vienna Information


9 . 1 . 10

Ribbons, bowsRubans, noeuds

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

29 . 1 . 8

BlackNoir

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 4

BlueBleu

29 . 1 . 3

GreenVert

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy.


Classification kind code

11

Class [042]
Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs; conducting genomic analysis, pre-clinical studies and clinical trials for others in the field of pharmaceutical preparations for treatment of diseases.


Classification kind code

11

Mark Details


Serial Number

2053617

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 18th Jan 2022
Approved
Submitted for opposition 27
on 18th Jan 2022
Approval Notice Sent
Submitted for opposition 22
on 12th Jan 2022
Search Recorded
Submitted for opposition 80
on 8th Dec 2021
Change of Title Registered
Submitted for opposition 256
on 26th Jul 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 24th Sept 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 23rd Sept 2020
Created
Submitted for opposition 31
on 23rd Sept 2020
Formalized
Submitted for opposition 30
on 7th Aug 2020
Filed
Submitted for opposition 228
on 7th Aug 2020
International Registration